Financial Crime Financial Crime

Alliance Pharma chief questioned in court appeal of drugmakers' UK antitrust fines

By Jon Menon
  • 08 Jun 2023 18:59
  • 08 Jun 2023 18:59
Alliance Pharmaceuticals’ chief executive Peter Butterfield came under pressure from questions in a London court today as the drugmaker and others argued to have fines for breaking UK competition rules overturned.
Alliance, Focus, Medreich and Lexon were fined a total of more than 35 million pounds ($43 million) last year

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

Latest News